Anthony Gringeri serves as Executive at ImmunoCellular Therapeutics, Ltd., where they oversee executive responsibilities. Since joining the company, Anthony Gringeri has executed 5 insider transactions totaling $28.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 11, 2016 involved receiving (via award) 75,000 shares valued at $0.
Anthony Gringeri currently holds 150,000 shares of ImmunoCellular Therapeutics, Ltd. (IMUC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anthony Gringeri has been a net buyer of IMUC stock. They have purchased $28.0K and sold $0 worth of shares.
Anthony Gringeri's most recent insider trade was on Mar 11, 2016, when they sold 75,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 18, 2015 | IMUC | $18.0K | Purchase | 30,000 | $0.60 | Discretionary |
| Aug 21, 2014 | IMUC | $10.0K | Purchase | 11,000 | $0.91 | Discretionary |
| Dec 23, 2013 | IMUC | $0 | Purchase | 25,000 | $N/A | Discretionary |